| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Elke Mühlberger | Q66680053 |
| P2093 | author name string | Kristina Schmidt | |
| P2860 | cites work | Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase | Q57081505 |
| Infectious defective interfering particles of VSV from transcripts of a cDNA clone | Q67490017 | ||
| Morphology of Marburg virus NP-RNA. | Q40724401 | ||
| Infectious rabies viruses from cloned cDNA. | Q40793123 | ||
| The nucleoprotein of Marburg virus is target for multiple cellular kinases | Q40970230 | ||
| Lack of Marburg Virus Transmission From Experimentally Infected to Susceptible In-Contact Egyptian Fruit Bats | Q41358863 | ||
| The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection | Q41822299 | ||
| Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate | Q42266175 | ||
| Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs. | Q42591160 | ||
| Marburg virus, a filovirus: méssenger RNAs, gene order, and regulatory elements of the replication cycle | Q42612213 | ||
| Marburgvirus resurgence in Kitaka Mine bat population after extermination attempts, Uganda | Q42939796 | ||
| Phosphorylation of Marburg virus VP30 at serines 40 and 42 is critical for its interaction with NP inclusions. | Q43706614 | ||
| Establishment and application of an infectious virus-like particle system for Marburg virus | Q43827238 | ||
| Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense | Q44322076 | ||
| Proteolytic processing of Marburg virus glycoprotein | Q45744301 | ||
| Interactions of Marburg virus nucleocapsid proteins | Q45753146 | ||
| Recovery of infectious human parainfluenza virus type 3 from cDNA. | Q45760781 | ||
| Marburg virus infection detected in a common African bat | Q21090111 | ||
| Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells | Q21090169 | ||
| Isolation of genetically diverse Marburg viruses from Egyptian fruit bats | Q21090516 | ||
| Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes | Q21131434 | ||
| Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with vero cells-adapted hogan strain of Marburg virus | Q21134043 | ||
| Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein | Q21245136 | ||
| Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus | Q21261526 | ||
| Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection | Q24329155 | ||
| Ebola virus entry requires the cholesterol transporter Niemann-Pick C1 | Q24329246 | ||
| Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola | Q24548936 | ||
| Decoding mechanisms by which silent codon changes influence protein biogenesis and function | Q26821951 | ||
| Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner | Q27313378 | ||
| Electron tomography reveals the steps in filovirus budding | Q27314945 | ||
| Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells | Q27323035 | ||
| Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus | Q27490714 | ||
| Crystal Structure of the Marburg Virus GP2 Core Domain in Its Postfusion Conformation | Q27671801 | ||
| Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism | Q27673907 | ||
| Structural basis for Marburg virus VP35-mediated immune evasion mechanisms | Q27675266 | ||
| The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway | Q27682227 | ||
| Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances | Q30544040 | ||
| Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems | Q33653597 | ||
| Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection | Q33680083 | ||
| Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes | Q33785253 | ||
| Studies of reservoir hosts for Marburg virus | Q33877879 | ||
| Cellular expression of a functional nodavirus RNA replicon from vaccinia virus vectors | Q33932394 | ||
| Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. | Q34028916 | ||
| Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30 | Q34301750 | ||
| Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture | Q34326549 | ||
| Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation | Q34362286 | ||
| Filovirus replication and transcription | Q34375243 | ||
| Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection | Q34440625 | ||
| Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment | Q34519791 | ||
| The VP40 protein of Marburg virus exhibits impaired budding and increased sensitivity to human tetherin following mouse adaptation | Q34594813 | ||
| High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses | Q34661133 | ||
| Marburg virus VP40 antagonizes interferon signaling in a species-specific manner. | Q35076858 | ||
| Sequence variability in viral genome non-coding regions likely contribute to observed differences in viral replication amongst MARV strains | Q35077488 | ||
| Structural basis for Marburg virus neutralization by a cross-reactive human antibody | Q35132751 | ||
| Mechanism of human antibody-mediated neutralization of Marburg virus | Q35132756 | ||
| Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread | Q35557172 | ||
| Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences | Q35826183 | ||
| Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex | Q35846673 | ||
| Reverse genetics of mononegavirales | Q35857608 | ||
| Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA. | Q35857613 | ||
| Transcription and replication of nonsegmented negative-strand RNA viruses. | Q35857617 | ||
| Filovirus entry into cells - new insights | Q35878069 | ||
| Experimental Inoculation of Egyptian Rousette Bats (Rousettus aegyptiacus) with Viruses of the Ebolavirus and Marburgvirus Genera | Q35895285 | ||
| Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles | Q35961320 | ||
| Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells | Q36043164 | ||
| Structural and Functional Studies on the Marburg Virus GP2 Fusion Loop | Q36043176 | ||
| Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model | Q36043232 | ||
| An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions | Q36141181 | ||
| Outbreak of Marburg hemorrhagic fever in Angola: a review of the history of the disease and its biological aspects | Q36207400 | ||
| Forty-five years of Marburg virus research | Q36395831 | ||
| Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins | Q36619514 | ||
| Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses | Q36650409 | ||
| Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs | Q36808047 | ||
| Clinical Management of Ebola Virus Disease in the United States and Europe | Q37149584 | ||
| The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus | Q37157191 | ||
| Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). | Q37255209 | ||
| Development and application of reporter-expressing mononegaviruses: current challenges and perspectives | Q37690397 | ||
| Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. | Q37700071 | ||
| Filovirus entry: a novelty in the viral fusion world | Q37999360 | ||
| Assembly of the Marburg virus envelope | Q38062931 | ||
| Host cell factors in filovirus entry: novel players, new insights | Q38076136 | ||
| Glycosylation and oligomerization of the spike protein of Marburg virus | Q38335344 | ||
| Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics | Q38363535 | ||
| A Single Amino Acid Change in the Marburg Virus Matrix Protein VP40 Provides a Replicative Advantage in a Species-Specific Manner | Q38818595 | ||
| Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial | Q38860437 | ||
| Marburg virus inclusions: A virus-induced microcompartment and interface to multivesicular bodies and the late endosomal compartment | Q38864560 | ||
| Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses | Q38926381 | ||
| Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. | Q39417023 | ||
| Phosphorylation of Marburg virus NP region II modulates viral RNA synthesis | Q39445116 | ||
| Phosphorylation of Marburg virus matrix protein VP40 triggers assembly of nucleocapsids with the viral envelope at the plasma membrane | Q39461698 | ||
| Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter | Q39548682 | ||
| Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions | Q39590625 | ||
| Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells | Q39601847 | ||
| Investigation of the Lipid Binding Properties of the Marburg Virus Matrix Protein VP40. | Q39603524 | ||
| Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles | Q39700080 | ||
| Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription | Q39796970 | ||
| Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection | Q39932766 | ||
| Basolateral budding of Marburg virus: VP40 retargets viral glycoprotein GP to the basolateral surface | Q40042145 | ||
| Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope | Q40176620 | ||
| Budding of Marburgvirus is associated with filopodia | Q40202125 | ||
| Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1. | Q40214327 | ||
| Multivesicular bodies as a platform for formation of the Marburg virus envelope | Q40277987 | ||
| Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease | Q40303984 | ||
| VP24 of Marburg virus influences formation of infectious particles | Q40361641 | ||
| Inhibition of Marburg virus protein expression and viral release by RNA interference | Q40512402 | ||
| Rescue of Ebola virus from cDNA using heterologous support proteins | Q40521892 | ||
| Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein | Q40541847 | ||
| The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway | Q40589969 | ||
| Termini of all mRNA species of Marburg virus: sequence and secondary structure | Q40663546 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| Marburg virus disease | Q167264 | ||
| reverse genetics | Q1897151 | ||
| Marburg marburgvirus | Q6755280 | ||
| biomedical investigative technique | Q66648976 | ||
| Marburgvirus | Q15728844 | ||
| P577 | publication date | 2016-06-22 | |
| P1433 | published in | Viruses | Q7935305 |
| P1476 | title | Marburg Virus Reverse Genetics Systems | |
| P478 | volume | 8 |
Search more.